REDWOOD CITY, Calif.
Nov. 8, 2012
/PRNewswire/ -- Cardica, Inc. (Nasdaq: CRDC) today announced that
Bernard A. Hausen
, M.D., Ph.D., the company's president and chief executive officer, is scheduled to present a corporate overview and update at the Lazard Capital Markets 9
Annual Healthcare Conference on
Wednesday, November 14
11:30 a.m. Eastern Standard Time
To access the live and subsequently archived webcast of the presentation, go to the Investor Relations section of the company's website at
. Please connect to the website at least 15 minutes prior to the presentation to allow for any necessary software downloads.
Cardica designs and manufactures proprietary stapling and anastomotic devices for cardiac and laparoscopic surgical procedures. Cardica's technology portfolio is intended to minimize operating time and enable minimally-invasive and robot-assisted surgeries. Cardica manufactures and markets its automated anastomosis systems, the C-Port
Distal Anastomosis Systems and PAS-Port
Proximal Anastomosis System for coronary artery bypass graft (CABG) surgery, and has shipped over 42,900 units throughout the world. In addition, Cardica is developing the Cardica MicroCutter XCHANGE™ 30, a cartridge-based microcutter device with a five-millimeter shaft diameter that is commercially available in the European Union, and the Cardica MicroCutter XPRESS™ 30, a true multi-fire laparoscopic stapling device. Both MicroCutter devices are designed to be used in a variety of procedures, including bariatric, colorectal, thoracic and general surgery. The Cardica MicroCutter XCHANGE 30 and XPRESS 30 products require 510(k) review and are not yet commercially available in the U.S.
SOURCE Cardica, Inc.